Iceland· IS-IS/1/23/038/01

Soltamcin

A tamsulosin und solifenacin product containing tamsulosinum inn hýdróklóríð,solifenacinum inn súkkínat, registered in Iceland by Williams & Halls ehf.. The same ATC class is registered in 9 of our 19 countries.

ATC G04CA53

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedSoltamcinATCG04CA53REGISTER NO.IS-IS/1/23/038/01PACKS LISTED2CHECKEDSeptember 29, 2026

Where it is registered

Tamsulosin und solifenacin is registered in 9 of 19 countries.

Countries holding a registration under ATC G04CA53 (tamsulosin und solifenacin), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 6 of them publish a price we can compare per daily dose

Tamsulosin und solifenacin · ATC G04CA53

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Tamsulosinum INN hýdróklóríð,Solifenacinum INN súkkínat
Manufacturer
Williams & Halls ehf.
Country
Iceland (IS)
ATC code
G04CA53
ATC class
Tamsulosin und Solifenacin
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 2

2 priced
  • ean
    410655
    30 stk x1 þpakki
    ISK 9571
  • ean
    525516
    90 stk x1 þpakki
    ISK 19539

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c4679093-59c9-41c5-b901-00487047957d
GET /v1/drugs/c4679093-59c9-41c5-b901-00487047957d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tafla með breyttan losunarhraða",
  "source": "lyfjastofnun",
  "atc_raw": "G04CA53",
  "marketed": true,
  "strength": "6 mg/0,4 mg",
  "ma_number": "IS/1/23/038/01",
  "substance": "Tamsulosinum INN hýdróklóríð,Solifenacinum INN súkkínat",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "45100"
}

See everything about tamsulosin und solifenacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.